Virax Biolabs Group Ltd
NASDAQ:VRAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
UK |
|
Ameriprise Financial Inc
NYSE:AMP
|
US |
|
Compass Group PLC
LSE:CPG
|
UK |
|
ABCO Energy Inc
OTC:ABCE
|
US |
|
F
|
Fortrea Holdings Inc
NASDAQ:FTRE
|
US |
|
Manugraph India Ltd
NSE:MANUGRAPH
|
IN |
|
Allovir Inc
NASDAQ:ALVR
|
US |
|
R
|
Rce Capital Bhd
KLSE:RCECAP
|
MY |
|
T
|
Tab Gida Sanayi ve Ticaret AS
IST:TABGD.E
|
TR |
|
MKB Nedsense NV
AEX:NEDSE
|
NL |
|
Arko Corp.
NASDAQ:ARKO
|
US |
|
C
|
Cosmos Yatirim Holding AS
IST:COSMO.E
|
TR |
|
DT Midstream Inc
NYSE:DTM
|
US |
|
Sportradar Group AG
NASDAQ:SRAD
|
CH |
|
Applied Visual Sciences Inc
OTC:APVS
|
US |
|
Terawulf Inc
NASDAQ:WULF
|
US |
|
Eumundi Group Ltd
ASX:EBG
|
AU |
|
COSCO Shipping Holdings Co Ltd
SSE:601919
|
CN |
|
M
|
Monadelphous Group Ltd
ASX:MND
|
AU |
|
B
|
Barunson Entertainment & Arts Corp
KOSDAQ:035620
|
KR |
|
Adyen NV
AEX:ADYEN
|
NL |
Wall Street
Price Targets
VRAX Price Targets Summary
Virax Biolabs Group Ltd
According to Wall Street analysts, the average 1-year price target for VRAX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VRAX's stock price target?
Price Target
1.02
USD
According to Wall Street analysts, the average 1-year price target for VRAX is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
What is Virax Biolabs Group Ltd's Revenue forecast?
Projected CAGR
2 445%
For the last 4 years the compound annual growth rate for Virax Biolabs Group Ltd's revenue is -52%. The projected CAGR for the next 2 years is 2 445%.
